HK Stock Market Move | 5100 XIZANG(01115) rose more than 5% recently, with a systematic study of the health functions of the "5100" product.

5100 XIZANG (01115) rose more than 5%, as of the time of writing, it increased by 5.43%, closing at 0.485 Hong Kong dollars, with a turnover of 8.3873 million Hong Kong dollars. On the news front, on April 28, 5100 XIZANG announced that on March 27, 2026, Jiafuli Investment Limited (a wholly-owned subsidiary of the company) and Professor Feng Yibin's team from the School of Chinese Medicine, The University of Hong Kong, signed a memorandum of cooperation, which involves conducting clinical efficacy evaluation research on XIZANG Glacier Mineral Water for patients with hyperuricemia and exploring the potential mechanism of mineral components of mineral water on uric acid metabolism and kidney excretion. As a representative enterprise in the field of natural drinking water in Tibet, the Group is committed to exploring the functional research of high-quality natural mineral water in the health and wellness sector. This collaboration aims to combine the traditional Chinese medicine concept of "food and medicine having the same source" with modern evidence-based medical research methods, to conduct systematic research on the health functions of the "5100" product, providing new research perspectives for the integration of traditional Chinese medicine clinical treatment and daily health management. The Board believes that this collaboration will help enhance the scientific research foundation of the Group's products and accumulate experience for future product development and technological innovation in the field of health and wellness.